New Data Reveals Burden of Oral Disease on Managed Care Plans
November 10, 2022
New research in Managed Care shows the burden of oral disease on managed care plans. The researchers looked at data from the IBM Watson Medicaid Marketscan data base, the IBM Dental Database, and the Medical Expenditure Panel Survey to ascertain the burden on Medicaid and commercial plans separately.
According to the researchers, “Estimates of caries-related treatments were calculated from IBM Watson and MEPS data for Medicaid enrollees (13% vs. 12%, respectively) and commercial claims (25% vs. 17%, respectively). Prevalence of periodontal related treatments for those with a dental visit was estimated for IBM Watson and MEPS enrollees for Medicaid (0.7% vs. 0.5%, respectively) and commercial claims (7% vs. 1.6%, respectively).”
To read more, click here.
(Source: Insurance News Net, November 9th, 2022)
